Acute toxicities and cumulative dose to the brain of repeated sessions of stereotactic radiotherapy (SRT) for brain metastases: a retrospective study of 184 patients

BACKGROUND: Stereotactic radiation therapy (SRT) is a focal treatment for brain metastases (BMs); thus, 20 to 40% of patients will require salvage treatment after an initial SRT session, either because of local or distant failure. SRT is not exempt from acute toxicity, and the acute toxicities of re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuntz, L., Le Fèvre, C., Jarnet, D., Keller, A., Meyer, P., Thiery, A., Cebula, H., Noel, G., Antoni, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830690/
https://www.ncbi.nlm.nih.gov/pubmed/36627646
http://dx.doi.org/10.1186/s13014-022-02194-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830690/
https://www.ncbi.nlm.nih.gov/pubmed/36627646
http://dx.doi.org/10.1186/s13014-022-02194-0

Ejemplares similares